Stay updated with breaking news from Nasdaq Prph. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ProPhase Labs, Inc. (NASDAQ:PRPH – Get Free Report)’s stock price passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $7.25 and traded as low as $4.35. ProPhase Labs shares last traded at $4.54, with a volume of 70,859 shares trading hands. Wall Street Analysts Forecast […]
ProPhase Labs (NASDAQ:PRPH – Get Free Report) was upgraded by analysts at StockNews.com from a “sell” rating to a “hold” rating in a report issued on Monday. Several other equities research analysts have also commented on the stock. TheStreet lowered shares of ProPhase Labs from a “b-” rating to a “c” rating in a research […]
ProPhase Labs, Inc. (NASDAQ:PRPH – Free Report) – HC Wainwright dropped their Q3 2023 EPS estimates for ProPhase Labs in a report released on Monday, August 14th. HC Wainwright analyst Y. Chen now anticipates that the company will post earnings per share of ($0.19) for the quarter, down from their prior forecast of ($0.17). HC […]
ProPhase Labs (NASDAQ:PRPH – Get Rating) had its price objective decreased by HC Wainwright from $15.00 to $14.00 in a report released on Friday, The Fly reports. A number of other research firms also recently weighed in on PRPH. TheStreet raised shares of ProPhase Labs from a c rating to a b- rating in a […]
ProPhase Labs, Inc. (NASDAQ:PRPH – Get Rating) was the recipient of a significant growth in short interest in April. As of April 15th, there was short interest totalling 382,800 shares, a growth of 23.5% from the March 31st total of 309,900 shares. Based on an average daily volume of 45,200 shares, the days-to-cover ratio is […]